Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumorsTomasz Wrzesiński, Joanna Wesoły, Hans A.R. Bluyssen et al.|BMC Cancer|2015Cited by 109
Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate CancerWojciech A. Cieślikowski, Andrzej Antczak, Martine Mazel et al.|Cancers|2020Cited by 41
Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration AssaysJoanna Budna, Catherine Alix‐Panabières, Martine Mazel et al.|Cancers|2019Cited by 32
Baseline CTC Count as a Predictor of Long-Term Outcomes in High-Risk Prostate CancerWojciech A. Cieślikowski, Joanna Budna, Agnieszka Ida et al.|Journal of Personalized Medicine|2023Cited by 13